Pre-market hot trades in US stocks: Bimergen Energy up 8.27% pre-market; Curis up 8.23% pre-marketPrice Alert·2 hours agoBESS-0.42%CRIS-2.16%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·21 hours agoALMR-4.95%GRI-1.73%
Curis regains Nasdaq bid-price compliance, remains under one-year panel monitorPUBT·Jul 30 at 03:05 PMCRIS-2.16%
Curis doses first five patients in TakeAim CLL combo trial of emavusertib, zanubrutinibPUBT·Jul 30 at 07:07 AMCRIS-2.16%
09:03 ETAssureCare® and CURIS Partner to Ensure RHT Funding Builds Infrastructure That Outlasts the Programprnewswire·Jul 27 at 08:03 AMCRIS-2.16%
Curis Gains As Blood Cancer Drug Progresses, December Readout in Focusbenzinga_article·Jul 24 at 01:03 PMCRIS-2.16%
CRIS: Emavusertib shows superior efficacy and safety in NHL, CLL, and AML, advancing in registrational trialsQuartr·Jul 22 at 09:05 AMCRIS-2.16%
CRIS: Emavusertib shows strong response rates in PCNSL and advances in CLL, pending further fundingQuartr·Jul 22 at 06:15 AMCRIS-2.16%
Curis notifies press release availability on positive emavusertib updatePUBT·Jul 22 at 06:04 AMCRIS-2.16%
Curis Consents First Six Patients in TakeAim CLL Study | CRIS Stock NewsStockTitan·Jul 6 at 12:30 AMCRIS-2.16%
